Purified anti-MOG Antibody, MOG, A24108A,BioLegend,648881

Host

Mouse

Reactivity

Human, Mouse, Rat

Application

IHC-P - Quality testedICC, WB, ICFC - Verified

Platform ID

BAB679053422

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-MOG Antibody, MOG, A24108A
Cat. No.648881
HostMouse
RRIDAB_3720623 (BioLegend Cat. No. 648880)AB_3720623 (BioLegend Cat. No. 648881)
IsotypeMouse IgG2b, κ
ReactivityHuman, Mouse, Rat
ApplicationIHC-P - Quality testedICC, WB, ICFC - Verified
ClonalityMonoclonal
Clone NumberA24108A
Concentration0.5 mg/mL
TargetMOG
ImmunogenRecombinant human MOG protein
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Myelin oligodendrocyte glycoprotein (MOG) is a type I transmembrane glycoprotein belonging to the immunoglobulin superfamily. This heavily N-glycosylated protein features a single extracellular immunoglobulin-like domain, a transmembrane region, and a short intracellular tail. MOG is expressed on the surface of oligodendrocytes in the outermost layer of myelin and is highly conserved across species. MOG plays a critical role in the completion and maintenance of the myelin sheath, possibly acting as a cell adhesion molecule that contributes to myelin integrity and immune regulation. MOG is notably implicated in a group of autoimmune demyelinating disorders collectively known as MOG antibody-associated disease (MOGAD). In these conditions, the immune system produces antibodies targeting MOG, leading to inflammation and damage in the optic nerves, spinal cord, and brain.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.